Correlation Between Tff Pharmaceuticals and Incyte
Can any of the company-specific risk be diversified away by investing in both Tff Pharmaceuticals and Incyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tff Pharmaceuticals and Incyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tff Pharmaceuticals and Incyte, you can compare the effects of market volatilities on Tff Pharmaceuticals and Incyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tff Pharmaceuticals with a short position of Incyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tff Pharmaceuticals and Incyte.
Diversification Opportunities for Tff Pharmaceuticals and Incyte
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tff and Incyte is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and Incyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Incyte and Tff Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tff Pharmaceuticals are associated (or correlated) with Incyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Incyte has no effect on the direction of Tff Pharmaceuticals i.e., Tff Pharmaceuticals and Incyte go up and down completely randomly.
Pair Corralation between Tff Pharmaceuticals and Incyte
If you would invest (100.00) in Tff Pharmaceuticals on December 27, 2024 and sell it today you would earn a total of 100.00 from holding Tff Pharmaceuticals or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Tff Pharmaceuticals vs. Incyte
Performance |
Timeline |
Tff Pharmaceuticals |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Incyte |
Tff Pharmaceuticals and Incyte Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Tff Pharmaceuticals and Incyte
The main advantage of trading using opposite Tff Pharmaceuticals and Incyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tff Pharmaceuticals position performs unexpectedly, Incyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Incyte will offset losses from the drop in Incyte's long position.Tff Pharmaceuticals vs. Gain Therapeutics | Tff Pharmaceuticals vs. In8bio Inc | Tff Pharmaceuticals vs. Lantern Pharma | Tff Pharmaceuticals vs. INmune Bio |
Incyte vs. Alnylam Pharmaceuticals | Incyte vs. United Therapeutics | Incyte vs. Ultragenyx | Incyte vs. Apellis Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |